Patent Law Weblog
Category: Biotech/Pharma Business
-
By Donald Zuhn — Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its Pitchbook-NVCA Venture Monitor report on venture funding for the fourth quarter of 2016, as well as for the year as a whole. With respect to the fourth quarter, the…
-
By Donald Zuhn — Earlier this year, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the second quarter of 2016. The report, which is prepared by the NVCA and PricewaterhouseCoopers LLP using data from Thomson Reuters, indicates…
-
By Kevin E. Noonan — Despite an understandable amount of gloom and doom in patenting circles regarding the effects of the recent Supreme Court and Federal Circuit jurisprudence on life sciences patents (Mayo v. Prometheus; AMP v. Myriad Genetics; Ariosa v. Sequenom as leading examples), investors appear to remain optimistic regarding the potential for successful commercialization…
-
By Kevin E. Noonan — One of the great benefits of scientific inquiry is the capacity for presumptions and prejudices from experience to be challenged and explained in ways that are counter-intuitive. This is true even for disciplines like economics, where the complexity of the variables involved (and the inability for most studies to be…
-
By Donald Zuhn –- A report issued by PwC's Health Research Institute (HRI) in June projects next year's medical cost trend (i.e., the projected percentage increase in the cost to treat patients) to be 6.5%, which is level to the medical cost trend for 2016 and comparable to the medical cost trend for the past…
-
By Donald Zuhn — Last month, the Biotechnology Industry Organization (BIO) announced the release of a BIO commissioned study that estimates the economic impact of academic licensing between 1996 and 2013. The study, entitled "The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2013," was prepared by Lori Pressman, David Roessner, Jennifer Bond, Sumiye…
-
By Cambria Alpha-Cobb* and Anthony D. Sabatelli** — Late last year, the Tufts Center for the Study of Drug Development (CSDD) released a number that would cause jaws to drop all around the healthcare world. The estimated cost for developing a new drug was an astounding $2.558 billion. Can we believe this number? If this…
-
By Donald Zuhn — Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2014. The report, which is prepared by NVCA and PriceWaterhouseCoopers LLP using data from Thomson Reuters, indicates that venture capitalists invested $48.3 billion…
-
By Donald Zuhn — Last week, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the third quarter of 2014. The report, which is prepared by the NVCA and PricewaterhouseCoopers LLP using data from Thomson Reuters, indicates that…
-
By Kevin E. Noonan — On Monday, Genetic Engineering and Biotechnology News (GEN) published a list of the Top 50 NIH-funded U.S. universities in fiscal year October 1st – September 30th. Geographically, California leads the list of most Federal research monies going to schools in the state. The list, set forth below, shows that private…
Patent Docs 